Key points are not available for this paper at this time.
Survival with improved functional status was better with HMII LVAD compared with OMM. Despite experiencing more frequent adverse events, LVAD patients improved more in HRQol and depression. The results support HMII use in functionally limited, noninotrope-dependent HF patients with poor HRQoL. (Risk Assessment and Comparative Effectiveness of Left Ventricular Assist Device LVAD and Medical Management ROADMAP; NCT01452802).
Estep et al. (Thu,) studied this question.